Increasing Incidence of Invasive Group A Streptococcus Disease in First Nations Population, Alberta, Canada, 2003-2017.
Alberta
Canada
First Nations
GAS
Streptococcus pyogenes
bacteria
emm type
high incidence
iGAS
invasive group A streptococcus disease
streptococci
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
entrez:
26
1
2021
pubmed:
27
1
2021
medline:
22
6
2021
Statut:
ppublish
Résumé
The incidence of invasive group A Streptococcus (iGAS) disease in the general population in Alberta, Canada, has been steadily increasing. To determine whether rates for specific populations such as First Nations are also increasing, we investigated iGAS cases among First Nations persons in Alberta during 2003-2017. We identified cases by isolating GAS from a sterile site and performing emm typing. We collected demographic, social, behavioral, and clinical data for patients. During the study period, 669 cases of iGAS in First Nations persons were reported. Incidence increased from 10.0 cases/100,000 persons in 2003 to 52.2 cases/100,000 persons in 2017. The 2017 rate was 6 times higher for the First Nations population than for non-First Nations populations (8.7 cases/100,000 persons). The 5 most common emm types from First Nations patients were 59, 101, 82, 41, and 11. These data indicate that iGAS is severely affecting the First Nations population in Alberta, Canada.
Identifiants
pubmed: 33496247
doi: 10.3201/eid2702.201945
pmc: PMC7853581
doi:
Substances chimiques
Antigens, Bacterial
0
Bacterial Outer Membrane Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
443-451Références
Vaccine. 2011 Oct 26;29(46):8175-8
pubmed: 21920403
Emerg Infect Dis. 2016 Apr;22(4):734-8
pubmed: 26982330
Am J Trop Med Hyg. 2011 Oct;85(4):703-10
pubmed: 21976576
Open Forum Infect Dis. 2016 Dec 07;4(1):ofw243
pubmed: 28480241
Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):E1768-76
pubmed: 24733896
Can Commun Dis Rep. 2018 Jul 05;44(7-8):182-188
pubmed: 31011300
Med J Aust. 2007 Jun 4;186(11):565-9
pubmed: 17547544
Lancet Infect Dis. 2009 Oct;9(10):611-6
pubmed: 19778763
mBio. 2017 Sep 19;8(5):
pubmed: 28928212
Clin Infect Dis. 2020 Jun 17;:
pubmed: 32803254
Microbiol Spectr. 2018 Sep;6(5):
pubmed: 30191802
Emerg Infect Dis. 2014 Apr;20(4):679-81
pubmed: 24655919
J Paediatr Child Health. 2002 Jun;38(3):229-34
pubmed: 12047688
Pediatr Infect Dis J. 2011 Apr;30(4):315-9
pubmed: 20948456
Clin Microbiol Infect. 2013 May;19(5):E222-9
pubmed: 23464795
Euro Surveill. 2017 Jan 19;22(3):
pubmed: 28128090
JAMA. 1993 Jan 20;269(3):384-9
pubmed: 8418346
J Clin Microbiol. 2016 Jan;54(1):134-41
pubmed: 26560536
BMC Infect Dis. 2014 Dec 31;14:727
pubmed: 25551178
J Clin Microbiol. 2006 Jun;44(6):2160-6
pubmed: 16757615
Am J Pathol. 2012 Apr;180(4):1522-34
pubmed: 22330677
Clin Infect Dis. 2010 Dec 1;51(11):1290-7
pubmed: 21034198
PLoS Negl Trop Dis. 2009 Jun 23;3(6):e467
pubmed: 19547749
J Clin Microbiol. 2005 Sep;43(9):4369-76
pubmed: 16145079
Emerg Infect Dis. 2015 Jan;21(1):177-9
pubmed: 25531562
J Infect Dis. 2014 Oct 15;210(8):1325-38
pubmed: 24799598
Epidemiol Infect. 2016 Apr;144(5):1018-27
pubmed: 26364646
Open Forum Infect Dis. 2018 Jul 20;5(8):ofy177
pubmed: 30109241
J Clin Microbiol. 2005 Apr;43(4):1678-83
pubmed: 15814984
Clin Microbiol Rev. 2000 Jul;13(3):470-511
pubmed: 10885988
Euro Surveill. 2017 May 11;22(19):
pubmed: 28537550
Lancet Infect Dis. 2005 Nov;5(11):685-94
pubmed: 16253886
PLoS One. 2006 Dec 20;1:e10
pubmed: 17183632